ATE448231T1 - Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen - Google Patents

Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen

Info

Publication number
ATE448231T1
ATE448231T1 AT07751984T AT07751984T ATE448231T1 AT E448231 T1 ATE448231 T1 AT E448231T1 AT 07751984 T AT07751984 T AT 07751984T AT 07751984 T AT07751984 T AT 07751984T AT E448231 T1 ATE448231 T1 AT E448231T1
Authority
AT
Austria
Prior art keywords
products
alpha
morphinan
beta
unsaturated ketone
Prior art date
Application number
AT07751984T
Other languages
English (en)
Inventor
Henry Buehler
William Dummitt
Anthony Mannino
Dennis Aubuchon
Hong Gu
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38326629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE448231(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE448231T1 publication Critical patent/ATE448231T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07751984T 2006-03-02 2007-03-02 Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen ATE448231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77825806P 2006-03-02 2006-03-02
PCT/US2007/005256 WO2007103105A2 (en) 2006-03-02 2007-03-02 Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds

Publications (1)

Publication Number Publication Date
ATE448231T1 true ATE448231T1 (de) 2009-11-15

Family

ID=38326629

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07751984T ATE448231T1 (de) 2006-03-02 2007-03-02 Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen

Country Status (10)

Country Link
US (8) US8871779B2 (de)
EP (1) EP1994034B1 (de)
JP (2) JP5695296B2 (de)
CN (1) CN101395159A (de)
AT (1) ATE448231T1 (de)
AU (1) AU2007224221B2 (de)
CA (1) CA2644095A1 (de)
DE (1) DE602007003197D1 (de)
MX (1) MX2008010921A (de)
WO (1) WO2007103105A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
TW201509943A (zh) 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP1971607A2 (de) 2005-11-22 2008-09-24 Controlled Chemicals, Inc. Verfahren zur reduzierung der konzentrationen an verunreinigendem michael-akzeptor in oxycodon und anderen zusammensetzungen
EP1994034B1 (de) * 2006-03-02 2009-11-11 Mallinckrodt, Inc. Verfahren zur herstellung von morphinan-6-on-produkten mit geringen konzentrationen von alpha-, beta-ungesättigten ketonverbindungen
US20080125592A1 (en) * 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
EP2073636B1 (de) * 2006-10-17 2012-09-05 Penick Corporation Verfahren für die herstellung von oxymorphon
CA2674915C (en) * 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
CA2671551C (en) 2006-12-04 2015-02-10 Noramco, Inc. Process for reducing impurities in oxycodone base
WO2008070658A1 (en) * 2006-12-04 2008-06-12 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
FR2923484B1 (fr) * 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
PE20120572A1 (es) 2009-07-22 2012-06-06 Gruenenthal Chemie Forma de dosificacion de oxidacion estabilizada resistente a la manipulacion
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
US8703950B2 (en) 2010-07-02 2014-04-22 Johnson Matthey Public Limited Co. Low ABUK oxycodone, its salts and methods of making same
PE20131102A1 (es) 2010-09-02 2013-10-12 Gruenenthal Chemie Forma de dosificacion resistente a manipulacion que comprende una sal inorganica
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
RS57913B1 (sr) 2012-04-18 2019-01-31 Gruenenthal Gmbh Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
TW201639855A (zh) 2012-07-16 2016-11-16 羅德科技公司 改良之類鴉片合成方法
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
MX368846B (es) 2013-07-12 2019-10-18 Gruenenthal Gmbh Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
GB201313211D0 (en) * 2013-07-24 2013-09-04 Cambrex Karlskoga Ab New process
GB201313915D0 (en) * 2013-08-02 2013-09-18 Johnson Matthey Plc Process
GB2517000B (en) 2013-08-02 2018-05-09 Johnson Matthey Plc Process for the synthesis of oxymorphone alkaloid and oxymorphone salts
EP3073994A1 (de) 2013-11-26 2016-10-05 Grünenthal GmbH Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels kryogenen mahlens
WO2015107471A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxycodone synthesis
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
EP3166948A1 (de) * 2014-07-09 2017-05-17 Rhodes Technologies Inc. Reduktion der anteile von alpha-, beta-ungesättigten ketonen in morphinanderivatzusammensetzungen
US9918979B2 (en) * 2015-01-29 2018-03-20 Johnson Matthey Public Limited Company Process of preparing low ABUK oxymorphone hydrochloride
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
WO2016187522A1 (en) * 2015-05-20 2016-11-24 Noramco, Inc. Process for the preparation of oxymorphone freebase
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
JP2023548356A (ja) * 2020-11-02 2023-11-16 ローズ テクノロジーズ ノルオキシモルホンを精製するための方法
CN114634514B (zh) * 2022-04-14 2024-04-09 甘肃农垦药物碱厂有限公司 一种去甲羟吗啡酮中杂质的去除方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009181A (en) 1935-07-23 Process for obtaining opium alka
US1479293A (en) 1924-01-01 Hiabtor fbettlid
FR1000543A (fr) 1946-02-26 1952-02-13 Roussel Uclaf Procédé d'extraction des alcaloïdes de l'opium
GB713689A (en) 1952-02-08 1954-08-18 T And H Smith Ltd A process for the extraction of alkaloids from poppy straw and/or capsules
US4435572A (en) 1978-04-26 1984-03-06 The United States Of America As Represented By The Department Of Health And Human Services Synthesis of ethyl-4(3'-methoxyphenyl)-1-methyl piperidine-3-carboxylate
NO793297L (no) 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
JPS55102538A (en) 1979-01-30 1980-08-05 Kawasaki Kasei Chem Ltd Preparation of p-n-alkyl benzoate
IT1129758B (it) 1980-01-23 1986-06-11 Montedison Spa Processo per la riduzione catalitica di chetoni insaturi
US4410700A (en) 1980-07-03 1983-10-18 The United States Of America As Represented By The Department Of Health And Human Services Preparation of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines by optical resolution
US4727146A (en) 1980-07-03 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Synthesis of chiral 1-benzyl-1,2,3,4-tetra-hydroisoquinolines by asymmetric reduction
US4556712A (en) 1981-05-20 1985-12-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation and racemization of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines
US4368326A (en) 1980-07-03 1983-01-11 Rice Kenner C Short total synthesis of dihydrothebainone, dihydrocodeinone, and nordihydroccodeinone
US4521601A (en) 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4613668A (en) 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
JPS60193902A (ja) 1984-03-16 1985-10-02 Mitsui Toatsu Chem Inc 害虫防除用組成物
US5459264A (en) 1992-12-21 1995-10-17 Shionogi Seiyaku Kabushiki Kaisha Method for reducing an α β-unsaturated ketone
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
US6046185A (en) 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
US6177567B1 (en) 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TW201509943A (zh) 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
WO2006084389A1 (de) 2005-02-11 2006-08-17 Cilag Ltd. Verfahren zur reinigung von noroxymorphon-verbindungen
PT2112153E (pt) 2005-03-04 2010-12-17 Euro Celtique Sa Método de diminuír a quantidade de cetonas insaturadas em alfa-beta em composições de opiáceos
EP1971607A2 (de) * 2005-11-22 2008-09-24 Controlled Chemicals, Inc. Verfahren zur reduzierung der konzentrationen an verunreinigendem michael-akzeptor in oxycodon und anderen zusammensetzungen
EP1994034B1 (de) 2006-03-02 2009-11-11 Mallinckrodt, Inc. Verfahren zur herstellung von morphinan-6-on-produkten mit geringen konzentrationen von alpha-, beta-ungesättigten ketonverbindungen
EP2073636B1 (de) 2006-10-17 2012-09-05 Penick Corporation Verfahren für die herstellung von oxymorphon
GB0624880D0 (en) 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
AU2008231127B2 (en) 2007-03-23 2013-05-02 SpecGx LLC Improved preparation of oxymorphone from oripavine

Also Published As

Publication number Publication date
US8748611B2 (en) 2014-06-10
US20220079938A1 (en) 2022-03-17
EP1994034B1 (de) 2009-11-11
JP5695296B2 (ja) 2015-04-01
US20200338068A1 (en) 2020-10-29
US20190381033A1 (en) 2019-12-19
US8871779B2 (en) 2014-10-28
JP2009528366A (ja) 2009-08-06
MX2008010921A (es) 2008-09-03
US20150148365A1 (en) 2015-05-28
AU2007224221A1 (en) 2007-09-13
AU2007224221B2 (en) 2013-02-14
WO2007103105A3 (en) 2007-11-22
WO2007103105A2 (en) 2007-09-13
CN101395159A (zh) 2009-03-25
CA2644095A1 (en) 2007-09-13
DE602007003197D1 (de) 2009-12-24
US20120059167A1 (en) 2012-03-08
JP2013173765A (ja) 2013-09-05
US20160243113A1 (en) 2016-08-25
EP1994034A2 (de) 2008-11-26
US20180008596A1 (en) 2018-01-11
US20080312442A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
ATE448231T1 (de) Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen
ATE430153T1 (de) Verfahren zur verminderung von alpha, beta- ungesättigten ketonen in opioidzusammensetzungen
DE602007007666D1 (de) Verfahren zur herstellung von nebivolol
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
MY148096A (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
ATE489354T1 (de) Verfahren zur herstellung von metallorganischen gerüstmaterialien hauptgruppen metallionen enthaltend
DE602004030239D1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE458535T1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
AT507172A3 (de) Verfahren zur herstellung von dibenz (c,e) (1,2)- oxaphosphorin-derivaten, amino-dibenz (c,e) (1,2)-oxaphosphorin sowie deren verwendung
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
UA107325C2 (uk) Спосіб обробки декоративних рослин
ATE452117T1 (de) Verfahren zur herstellung von cyclischen ketonen
DE602005020185D1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
DE602007003198D1 (de) Verfahren zur herstellung einer zusammensetzung auf 4-hydroxyprolin-basis sowie verwendungen davon auf landwirtschaftlichem gebiet
IL183104A0 (en) Method for production of candesartan
DE602006019870D1 (de) Verfahren zur synthese von triazolen
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE515502T1 (de) Verfahren zur herstellung von tetranorlabdanderivaten
ATE501115T1 (de) Verfahren zur herstellung von entacapon
ATE487730T1 (de) Verfahren zur herstellung eines oxaliplatins
ATE381532T1 (de) Verfahren zur herstellung von gabapentin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties